Xilio Therapeutics, Inc. Stock Forecast
Big movements in Xilio Therapeutics, Inc. stock price on Friday moving 17.30% between high and low
(Updated on May 03, 2024)
The Xilio Therapeutics, Inc. stock price gained 12.38% on the last trading day (Friday, 3rd May 2024), rising from $1.05 to $1.18. During the last trading day the stock fluctuated 17.30% from a day low at $1.04 to a day high of $1.22. The price has fallen in 5 of the last 10 days but is still up by 2.61% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 82 thousand more shares were traded than the day before. In total, 265 thousand shares were bought and sold for approximately $312.56 thousand.
The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 70.07% during the next 3 months and, with a 90% probability hold a price between $1.62 and $3.10 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
XLO Signals & Forecast
The Xilio Therapeutics, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $1.07 and $1.07. A breakdown below any of these levels will issue sell signals. Xilio Therapeutics, Inc. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Monday, April 01, 2024, and so far it has fallen -22.88%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).
Support, Risk & Stop-loss for Xilio Therapeutics, Inc. stock
On the downside, the stock finds support just below today's level from accumulated volume at $1.08 and $1.05. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Xilio Therapeutics, Inc. finds support just below today's level at $1.08. If this is broken, then the next support from accumulated volume will be at $1.05 and $1.04.
This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.180 between high and low, or 17.30%. For the last week, the stock has had daily average volatility of 11.53%.
Our recommended stop-loss: $1.11 (-5.93%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 24 days ago.)
Trading Expectations (XLO) For The Upcoming Trading Day Of Monday 6th
For the upcoming trading day on Monday, 6th we expect Xilio Therapeutics, Inc. to open at $1.15, and during the day (based on 14 day Average True Range), to move between $1.03 and $1.33, which gives a possible trading interval of +/-$0.148 (+/-12.50%) up or down from last closing price. If Xilio Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 25.01% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $1.21 (2.54%) than the support at $1.08 (8.47%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Xilio Therapeutics, Inc. stock A Buy?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Xilio Therapeutics, Inc. stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Buy candidate.
Current score: 3.374 Buy Candidate Upgraded
Predicted Opening Price for Xilio Therapeutics, Inc. of Monday, May 6, 2024
| Fair opening price May 6, 2024 | Current price |
|---|---|
| $1.15 ( 2.83%) | $1.18 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for XLO
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 1.33 | 12.42 % | |
| R2 | 1.26 | 6.59 % | ||
| R1 | 1.22 | 3.00 % | ||
| Current price: | 1.18 | |||
| Support | S1 | 1.08 | -8.65 % | |
| S2 | 1.04 | -12.25 % | ||
| S3 | 0.97 | -18.07 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 1.47 | 24.58 % | |
| R2 | 1.30 | 10.17 % | ||
| R1 | 1.21 | 2.54 % | ||
| Current price | 1.18 | |||
| Support | S1 | 1.08 | -8.47% | |
| S2 | 1.05 | -11.02% | ||
| S3 | 1.04 | -11.86% |
FAQ
Click here for our free guide on how to buy Xilio Therapeutics, Inc. Stock.
